Literature DB >> 1462123

Spontaneous in vivo gene transcription of interleukin-2, interleukin-3, interleukin-4, interleukin-6, interferon-gamma, interleukin-2 receptor (CD25) and proto-oncogene c-myc by rheumatoid synovial T lymphocytes.

K Waalen1, M Sioud, J B Natvig, O Førre.   

Abstract

Rheumatoid synovial T lymphocytes were investigated for the presence of mRNA for the cytokines interleukin-2, -3, -4, -6, interferon-gamma, the interleukin-2 receptor (CD25) and the proto-oncogene c-myc. The isolated RNAs were analysed by dot blot and Northern blot hybridization. Our results show that synovial T lymphocytes from patients with rheumatoid arthritis (n = 12) had spontaneous in vivo gene transcription of interleukin-2 (93%), interleukin-4 (67%), interleukin-6 (92%), interleukin-2 receptor (92%) and the proto-oncogene c-myc (67%). Only a few of the RA patients had synovial T cells with increased expression of mRNA for interleukin-3 (25%) and interferon-gamma (25%). The amounts of mRNA for the various cytokines and activation molecules produced by the rheumatoid synovial T lymphocytes were in most instances comparable to those of normal peripheral blood T lymphocytes activated in vitro by the mitogen phytohaemagglutinin. The data thus indicate that the synovial T lymphocytes are activated in vivo in the majority of rheumatoid arthritis patients.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1462123     DOI: 10.1111/j.1365-3083.1992.tb03148.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  10 in total

1.  Evaluation of synovial cytokine patterns in rheumatoid arthritis and osteoarthritis by quantitative reverse transcription polymerase chain reaction.

Authors:  S Wagner; P Fritz; H Einsele; S Sell; J G Saal
Journal:  Rheumatol Int       Date:  1997       Impact factor: 2.631

2.  Association between a single-nucleotide polymorphism in the promoter of the human interleukin-3 gene and rheumatoid arthritis in Japanese patients, and maximum-likelihood estimation of combinatorial effect that two genetic loci have on susceptibility to the disease.

Authors:  R Yamada; T Tanaka; M Unoki; T Nagai; T Sawada; Y Ohnishi; T Tsunoda; M Yukioka; A Maeda; K Suzuki; H Tateishi; T Ochi; Y Nakamura; K Yamamoto
Journal:  Am J Hum Genet       Date:  2001-02-14       Impact factor: 11.025

3.  CIP2A facilitates apoptotic resistance of fibroblast-like synoviocytes in rheumatoid arthritis independent of c-Myc expression.

Authors:  Jaejoon Lee; Hyemin Jeong; Eun-Jung Park; Ji Won Hwang; Bo Huang; Eun-Kyung Bae; Joong Kyong Ahn; Hoon-Suk Cha; Eun-Mi Koh
Journal:  Rheumatol Int       Date:  2013-03-02       Impact factor: 2.631

4.  Spontaneous expression of IL-4 mRNA in lymphocytes from children with atopic dermatitis.

Authors:  M L Tang; A S Kemp
Journal:  Clin Exp Immunol       Date:  1994-09       Impact factor: 4.330

5.  Reduced interferon-gamma (IFN-gamma) secretion with increased IFN-gamma mRNA expression in atopic dermatitis: evidence for a post-transcriptional defect.

Authors:  M L Tang; G Varigos; A S Kemp
Journal:  Clin Exp Immunol       Date:  1994-09       Impact factor: 4.330

Review 6.  T cell receptor analysis in rheumatoid arthritis: what have we learnt?

Authors:  S H Zwillich; D B Weiner; W V Williams
Journal:  Immunol Res       Date:  1994       Impact factor: 2.829

7.  Divergent T-cell cytokine patterns in inflammatory arthritis.

Authors:  A K Simon; E Seipelt; J Sieper
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-30       Impact factor: 11.205

Review 8.  T-cell antigen receptors in rheumatoid arthritis.

Authors:  L I Sakkas; P F Chen; C D Platsoucas
Journal:  Immunol Res       Date:  1994       Impact factor: 2.829

9.  T cells and T-cell cytokine transcripts in the synovial membrane in patients with osteoarthritis.

Authors:  L I Sakkas; C Scanzello; N Johanson; J Burkholder; A Mitra; P Salgame; C D Katsetos; C D Platsoucas
Journal:  Clin Diagn Lab Immunol       Date:  1998-07

10.  CD25brightCD4+ regulatory T cells are enriched in inflamed joints of patients with chronic rheumatic disease.

Authors:  Duojia Cao; Ronald van Vollenhoven; Lars Klareskog; Christina Trollmo; Vivianne Malmström
Journal:  Arthritis Res Ther       Date:  2004-06-07       Impact factor: 5.156

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.